Breatheasy MIIST
Alameda, US · Founded 2019 · Delaware corporation · 2 known investors
Miist develops inhaled microparticle therapeutics that deliver medicine to the bloodstream in 30 seconds, targeting conditions like migraine, pain, and anxiety where rapid onset is critical. The company is advancing a portfolio of systemic therapies starting with MST-02, a migraine treatment designed to work significantly faster than existing oral medications.
Founders & leadership
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$6.3MraisedSep 2024 · 11 investors · Other Health CareRule 506(b)
▶$6.3MraisedSep 2024 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Randy KrebsExecutive Officer
- Dalton SignorExecutive Officer, Director, Promoter
- Offering amount
- $8.4M
- Amount sold
- $6.3M
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$75KraisedOct 2022 · 2 investors · Other Health CareRule 506(b)
▶$75KraisedOct 2022 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Dalton SignorExecutive Officer, Director
- Randy KrebsExecutive Officer, Director
- Evan AlfanoDirector
- Eric EzerinsExecutive Officer
- Jeffrey SchusterExecutive Officer
- Offering amount
- $75K
- Amount sold
- $75K
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.